ARCHIVES

Committee Approves NDA For Tamoxifen

This article is from The Cancer Letter archive.

Vol. 03 No. 03 | January 21, 1977

Download PDF Visit The Full Archive

Related Articles

Cancer Program Advocates Seek $170 Mil. Above President’s Budget, Vow To Close Bypass Gap

May 8, 1992

AACR Elion Award Deadline Is Jan. 10

September 16, 1994

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

Funding Opportunities

December 13, 2002

Henderson Committee Final Recommendation Made On P01s

February 10, 1984

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

May 18, 2007